ÂÜÀòÂÒÂ×

Ignacio Anglada is an accomplished financial executive with extensive experience in various leadership roles within the pharmaceutical industry. Currently serving as Group Chief Financial Officer at Julphar since May 2022, Ignacio has previously held significant positions at Lonza and Novartis, where responsibilities included Finance Director for the Biologics Division and Global Finance Head for Anti-Infectives and Chemical Operations. Earlier in a career that began at Arthur Andersen & Co. as a Junior Auditor, Ignacio has built a strong foundation in finance through progressive roles at DERBI (Grupo Piaggio) and various capacities at Novartis. Ignacio's academic credentials include an Executive Finance Excellence program at Harvard Business School, an MBA from Esade, and a Bachelor's degree in Economics and Business Administration from Universitat de Barcelona.